Greencross Reference Laboratory, Seoul, Korea.
J Korean Med Sci. 2012 Oct;27(10):1273-7. doi: 10.3346/jkms.2012.27.10.1273. Epub 2012 Oct 2.
Terminal or interstitial deletions of Xp (Xp22.2→Xpter) in males have been recognized as a cause of contiguous gene syndromes showing variable association of apparently unrelated clinical manifestations such as Leri-Weill dyschondrosteosis (SHOX), chondrodysplasia punctata (CDPX1), mental retardation (NLGN4), ichthyosis (STS), Kallmann syndrome (KAL1), and ocular albinism (GPR143). Here we present a case of a 13.5 yr old boy and sister with a same terminal deletion of Xp22.2 resulting in the absence of genes from the telomere of Xp to GPR143 of Xp22. The boy manifested the findings of all of the disorders mentioned above. We began a testosterone enanthate monthly replacement therapy. His sister, 11 yr old, manifested only Leri-Weill dyschondrosteosis, and had engaged in growth hormone therapy for 3 yr. To the best of our knowledge, this is the first report of a male with a 9.7 Mb terminal Xp deletion including the OA1 locus in Korea.
男性 Xp 端粒至间粒缺失(Xp22.2→Xpter)已被认为是连续基因综合征的一个原因,这些综合征表现出明显不相关的临床表现的不同组合,如 Leri-Weill 软骨发育不全症(SHOX)、点状软骨发育不良(CDPX1)、智力障碍(NLGN4)、鱼鳞病(STS)、卡尔曼综合征(KAL1)和眼白化病(GPR143)。在这里,我们报告了一例 13.5 岁男孩和他的姐姐,他们都存在 Xp22.2 端粒缺失,导致 Xp 端粒到 Xp22.2 的 GPR143 之间的基因缺失。该男孩表现出上述所有疾病的发现。我们开始每月进行睾酮庚酸酯替代治疗。他 11 岁的姐姐仅表现出 Leri-Weill 软骨发育不全症,并已接受生长激素治疗 3 年。据我们所知,这是首例在韩国报道的男性 Xp 端粒缺失 9.7Mb,包括 OA1 基因座。